• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多民族东南亚社区30天心力衰竭再入院风险分层模型

Risk Stratification Model for 30-Day Heart Failure Readmission in a Multiethnic South East Asian Community.

作者信息

Leong Kui Toh Gerard, Wong Lai Yin, Aung Khin Chaw Yu, Macdonald Michael, Cao Yan, Lee Sheldon, Chow Wai Leng, Doddamani Sanjay, Richards Arthur Mark

机构信息

Department of Cardiology, Changi General Hospital, Singapore, Singapore.

Health Services Research Department, Eastern Health Alliance, Singapore, Singapore.

出版信息

Am J Cardiol. 2017 May 1;119(9):1428-1432. doi: 10.1016/j.amjcard.2017.01.026. Epub 2017 Feb 10.

DOI:10.1016/j.amjcard.2017.01.026
PMID:28302271
Abstract

There are limited accurate 30-day heart failure (HF) readmission risk scores using readily available clinical patient information on a well-defined HF cohort. We analyzed 1,475 admissions discharged from our hospital with a primary diagnosis of HF between 2010 and 2012. HF diagnostic criteria included satisfying clinical Framingham criteria, elevated serum N-terminal pro-natriuretic peptide, and evidence of cardiac dysfunction on transthoracic echocardiography. The patients were randomly divided into 2 groups; 60% were used as the derivation cohort and 40% as the validation cohort. Bivariate analysis and logistic regression were used to develop the model. Weighted risk scores were derived from the odds ratio of the logistic regression model. Total risk scores were computed by simple summation for each patient. The 7 significant independent predictors of 30-day HF readmission used to derive the risk scoring tool were the number of previous HF-related admission in the preceding 1 year, index admission length of stay, serum creatinine level, electrocardiograph QRS duration, serum N-terminal pro-natriuretic peptide level, number of Medical Social Service needs, and β blocker prescription on discharge. The area under the curve was 0.76. Sensitivity and specificity were 78.3% and 60.7%, respectively. The positive predictive value and negative predictive value were 18.9% and 96%, respectively. The actual observed and predicted 30-day heart failure readmission rates matched. In conclusion, we have developed the first 30-day HF readmission risk score, with good discriminatory ability, for an urban multiethnic Asian heart failure cohort with stringent diagnostic criteria. It consists of 7 easily obtained variables.

摘要

利用明确界定的心力衰竭(HF)队列中易于获取的临床患者信息,准确的30天HF再入院风险评分有限。我们分析了2010年至2012年间我院出院的1475例主要诊断为HF的患者。HF诊断标准包括满足临床弗明翰标准、血清N末端前脑钠肽升高以及经胸超声心动图显示心脏功能障碍的证据。患者被随机分为两组;60%用作推导队列,40%用作验证队列。采用双变量分析和逻辑回归建立模型。加权风险评分来自逻辑回归模型的比值比。通过对每位患者进行简单求和计算总风险评分。用于推导风险评分工具的30天HF再入院的7个重要独立预测因素是前1年与HF相关的入院次数、本次入院住院时间、血清肌酐水平、心电图QRS时限、血清N末端前脑钠肽水平、医疗社会服务需求数量以及出院时β受体阻滞剂处方情况。曲线下面积为0.76。敏感性和特异性分别为78.3%和60.7%。阳性预测值和阴性预测值分别为18.9%和96%。实际观察到的和预测的30天心力衰竭再入院率相符。总之,我们为诊断标准严格的城市多民族亚洲心力衰竭队列开发了首个具有良好鉴别能力的30天HF再入院风险评分。它由7个易于获得的变量组成。

相似文献

1
Risk Stratification Model for 30-Day Heart Failure Readmission in a Multiethnic South East Asian Community.多民族东南亚社区30天心力衰竭再入院风险分层模型
Am J Cardiol. 2017 May 1;119(9):1428-1432. doi: 10.1016/j.amjcard.2017.01.026. Epub 2017 Feb 10.
2
Early inpatient calculation of laboratory-based 30-day readmission risk scores empowers clinical risk modification during index hospitalization.早期在住院期间计算基于实验室检查的30天再入院风险评分,有助于在首次住院期间进行临床风险调整。
Am Heart J. 2017 Mar;185:101-109. doi: 10.1016/j.ahj.2016.12.010. Epub 2016 Dec 29.
3
Risk prediction for 30-day heart failure-specific readmission or death after discharge: Data from the Korean Acute Heart Failure (KorAHF) registry.出院后 30 天内心力衰竭特定再入院或死亡的风险预测:来自韩国急性心力衰竭(KorAHF)注册研究的数据。
J Cardiol. 2019 Feb;73(2):108-113. doi: 10.1016/j.jjcc.2018.07.009. Epub 2018 Oct 22.
4
Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.心力衰竭患者住院期间 N 末端 B 型利钠肽原的急性变化与再入院和死亡率的关系。
Am J Cardiol. 2011 Apr 15;107(8):1191-5. doi: 10.1016/j.amjcard.2010.12.018. Epub 2011 Feb 4.
5
Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.手持超声评估下腔静脉与N末端脑钠肽前体对急性失代偿性心力衰竭住院后再入院预测的比较
JACC Cardiovasc Imaging. 2008 Sep;1(5):595-601. doi: 10.1016/j.jcmg.2008.06.005.
6
Electronic medical record-based model to predict the risk of 90-day readmission for patients with heart failure.基于电子病历的心力衰竭患者 90 天再入院风险预测模型。
BMC Med Inform Decis Mak. 2019 Oct 15;19(1):193. doi: 10.1186/s12911-019-0915-8.
7
Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.心力衰竭患者入院期间及出院后早期使用连续N末端B型利钠肽原测量进行风险分层:PRIMA研究的事后分析
J Card Fail. 2014 Dec;20(12):881-90. doi: 10.1016/j.cardfail.2014.08.014. Epub 2014 Aug 28.
8
A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.纳入 N 末端脑利钠肽前体水平的急性失代偿性心力衰竭患者新型出院风险模型:急性失代偿性心力衰竭的欧洲合作:ELAN-HF 评分。
Heart. 2014 Jan;100(2):115-25. doi: 10.1136/heartjnl-2013-303632. Epub 2013 Oct 31.
9
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.N-末端脑利钠肽前体指导的强化患者管理联合多学科治疗对慢性心力衰竭患者的影响:一项 3 臂前瞻性随机对照研究
J Am Coll Cardiol. 2010 Feb 16;55(7):645-53. doi: 10.1016/j.jacc.2009.08.078.
10
Comparison of Characteristics and Outcomes of Heart Failure Patients With Preserved Versus Reduced Ejection Fraction in a Multiethnic Southeast Asian Cohort.多民族东南亚队列中射血分数保留与降低的心力衰竭患者的特征及结局比较
Am J Cardiol. 2016 Oct 15;118(8):1233-1238. doi: 10.1016/j.amjcard.2016.07.039. Epub 2016 Jul 29.

引用本文的文献

1
Predicting death or readmission following heart failure hospitalisation: the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry.预测心力衰竭住院后的死亡或再入院情况:温哥华海岸急性心力衰竭(VOCAL-AHF)登记研究
Open Heart. 2025 Jun 3;12(1):e003210. doi: 10.1136/openhrt-2025-003210.
2
Integrating SHAP analysis with machine learning to predict postpartum hemorrhage in vaginal births.将SHAP分析与机器学习相结合以预测阴道分娩中的产后出血。
BMC Pregnancy Childbirth. 2025 May 3;25(1):529. doi: 10.1186/s12884-025-07633-w.
3
Machine learning for the prediction of sepsis-related death: a systematic review and meta-analysis.
机器学习在脓毒症相关死亡预测中的应用:系统评价和荟萃分析。
BMC Med Inform Decis Mak. 2023 Dec 11;23(1):283. doi: 10.1186/s12911-023-02383-1.
4
Rate of Rehospitalization in 60 Days of Discharge and It's Determinants in Patients with Heart Failure with Reduced Ejection Fraction in a Tertiary Care Centre in India.印度一家三级医疗中心射血分数降低的心力衰竭患者出院60天内的再住院率及其影响因素
Int J Heart Fail. 2020 Apr 21;2(2):131-144. doi: 10.36628/ijhf.2020.0007. eCollection 2020 Apr.
5
Readmission Risk Prediction Model for Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis.慢性心力衰竭患者再入院风险预测模型:系统评价与Meta分析
Iran J Public Health. 2022 Jul;51(7):1481-1493. doi: 10.18502/ijph.v51i7.10082.
6
Saudi Heart Association Position Statement on the Use of Biomarkers for the Management of Heart Failure and Acute Coronary Syndrome.沙特心脏协会关于使用生物标志物管理心力衰竭和急性冠状动脉综合征的立场声明。
J Saudi Heart Assoc. 2022 Aug 13;34(2):114-123. doi: 10.37616/2212-5043.1308. eCollection 2022.
7
A Model for the Prediction of Mortality and Hospitalization in Chinese Heart Failure Patients.中国心力衰竭患者死亡率和住院率预测模型
Front Cardiovasc Med. 2021 Nov 18;8:761605. doi: 10.3389/fcvm.2021.761605. eCollection 2021.
8
Association Between Left Ventricular Global Function Index and Outcomes in Patients With Dilated Cardiomyopathy.扩张型心肌病患者左心室整体功能指数与预后的关系
Front Cardiovasc Med. 2021 Nov 16;8:751907. doi: 10.3389/fcvm.2021.751907. eCollection 2021.
9
Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study.预测慢性心力衰竭180天再入院风险列线图的开发与验证:一项多中心前瞻性研究
Front Cardiovasc Med. 2021 Sep 7;8:731730. doi: 10.3389/fcvm.2021.731730. eCollection 2021.
10
Prediction models for hospital readmissions in patients with heart disease: a systematic review and meta-analysis.预测心脏病患者住院再入院的模型:系统评价和荟萃分析。
BMJ Open. 2021 Aug 17;11(8):e047576. doi: 10.1136/bmjopen-2020-047576.